

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tryptophan catabolic process (GO:0006569) | 5.09833174 |
| 2 | indole-containing compound catabolic process (GO:0042436) | 5.09833174 |
| 3 | indolalkylamine catabolic process (GO:0046218) | 5.09833174 |
| 4 | aromatic amino acid family catabolic process (GO:0009074) | 4.92948687 |
| 5 | glyoxylate metabolic process (GO:0046487) | 4.90935109 |
| 6 | kynurenine metabolic process (GO:0070189) | 4.89622873 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.86724536 |
| 8 | cysteine metabolic process (GO:0006534) | 4.85953204 |
| 9 | urea metabolic process (GO:0019627) | 4.79029493 |
| 10 | urea cycle (GO:0000050) | 4.79029493 |
| 11 | tryptophan metabolic process (GO:0006568) | 4.75803419 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 4.63658390 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.55335597 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 4.55335597 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.53360578 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 4.53360578 |
| 17 | lysine metabolic process (GO:0006553) | 4.49612630 |
| 18 | lysine catabolic process (GO:0006554) | 4.49612630 |
| 19 | glycine metabolic process (GO:0006544) | 4.48084883 |
| 20 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.42794723 |
| 21 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.41221347 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 4.41063316 |
| 23 | cellular glucuronidation (GO:0052695) | 4.38255627 |
| 24 | homocysteine metabolic process (GO:0050667) | 4.30296974 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.26468486 |
| 26 | amino-acid betaine metabolic process (GO:0006577) | 4.24586677 |
| 27 | bile acid biosynthetic process (GO:0006699) | 4.24395791 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.18203568 |
| 29 | low-density lipoprotein particle remodeling (GO:0034374) | 4.17793863 |
| 30 | alpha-linolenic acid metabolic process (GO:0036109) | 4.13824287 |
| 31 | serine family amino acid metabolic process (GO:0009069) | 4.08776178 |
| 32 | regulation of hexokinase activity (GO:1903299) | 4.05473253 |
| 33 | regulation of glucokinase activity (GO:0033131) | 4.05473253 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 4.05073464 |
| 35 | serine family amino acid biosynthetic process (GO:0009070) | 4.03689868 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.02031811 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.02031811 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.02031811 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 3.98165775 |
| 40 | complement activation, alternative pathway (GO:0006957) | 3.98102816 |
| 41 | regulation of protein activation cascade (GO:2000257) | 3.93990360 |
| 42 | negative regulation of sterol transport (GO:0032372) | 3.93635752 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 3.93635752 |
| 44 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.91180972 |
| 45 | protein carboxylation (GO:0018214) | 3.91112105 |
| 46 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.91112105 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 3.86565335 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.80749259 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 3.80303371 |
| 50 | inositol phosphate catabolic process (GO:0071545) | 3.77425794 |
| 51 | respiratory chain complex IV assembly (GO:0008535) | 3.75576291 |
| 52 | glutamate metabolic process (GO:0006536) | 3.73963418 |
| 53 | one-carbon metabolic process (GO:0006730) | 3.69106389 |
| 54 | glucuronate metabolic process (GO:0019585) | 3.67015578 |
| 55 | uronic acid metabolic process (GO:0006063) | 3.67015578 |
| 56 | tetrahydrofolate metabolic process (GO:0046653) | 3.64845120 |
| 57 | regulation of complement activation (GO:0030449) | 3.64334242 |
| 58 | imidazole-containing compound metabolic process (GO:0052803) | 3.63168194 |
| 59 | flavonoid metabolic process (GO:0009812) | 3.62220640 |
| 60 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.60827477 |
| 61 | regulation of fibrinolysis (GO:0051917) | 3.59522968 |
| 62 | bile acid and bile salt transport (GO:0015721) | 3.57668741 |
| 63 | acylglycerol homeostasis (GO:0055090) | 3.54773625 |
| 64 | triglyceride homeostasis (GO:0070328) | 3.54773625 |
| 65 | NAD biosynthetic process (GO:0009435) | 3.54467889 |
| 66 | bile acid metabolic process (GO:0008206) | 3.54171527 |
| 67 | carnitine metabolic process (GO:0009437) | 3.53496351 |
| 68 | lactate metabolic process (GO:0006089) | 3.53055748 |
| 69 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.52271513 |
| 70 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.52271513 |
| 71 | ketone body metabolic process (GO:1902224) | 3.50461175 |
| 72 | inositol phosphate dephosphorylation (GO:0046855) | 3.48897501 |
| 73 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.48897501 |
| 74 | regulation of triglyceride catabolic process (GO:0010896) | 3.48455286 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 3.47120032 |
| 76 | protein K6-linked ubiquitination (GO:0085020) | 3.46229488 |
| 77 | aromatic amino acid family metabolic process (GO:0009072) | 3.45801335 |
| 78 | reverse cholesterol transport (GO:0043691) | 3.45124165 |
| 79 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.42517586 |
| 80 | amine catabolic process (GO:0009310) | 3.41462171 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 3.41462171 |
| 82 | urate metabolic process (GO:0046415) | 3.41275918 |
| 83 | drug catabolic process (GO:0042737) | 3.38187874 |
| 84 | indolalkylamine metabolic process (GO:0006586) | 3.35489301 |
| 85 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.35321566 |
| 86 | phospholipid efflux (GO:0033700) | 3.33875243 |
| 87 | blood coagulation, intrinsic pathway (GO:0007597) | 3.33275536 |
| 88 | nuclear pore complex assembly (GO:0051292) | 3.32327298 |
| 89 | presynaptic membrane assembly (GO:0097105) | 3.30093553 |
| 90 | cytochrome complex assembly (GO:0017004) | 3.28509430 |
| 91 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.27707205 |
| 92 | regulation of DNA endoreduplication (GO:0032875) | 3.25205556 |
| 93 | mitotic sister chromatid cohesion (GO:0007064) | 3.24147259 |
| 94 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.22102791 |
| 95 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.22102791 |
| 96 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.22102791 |
| 97 | exogenous drug catabolic process (GO:0042738) | 3.17381401 |
| 98 | endocrine pancreas development (GO:0031018) | 3.17234167 |
| 99 | 2-oxoglutarate metabolic process (GO:0006103) | 3.15350329 |
| 100 | fructose metabolic process (GO:0006000) | 3.14743055 |
| 101 | aspartate family amino acid catabolic process (GO:0009068) | 3.13336249 |
| 102 | response to nitrosative stress (GO:0051409) | 3.12957870 |
| 103 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.11725396 |
| 104 | benzene-containing compound metabolic process (GO:0042537) | 3.11678667 |
| 105 | cellular modified amino acid catabolic process (GO:0042219) | 3.11216876 |
| 106 | positive regulation of protein autophosphorylation (GO:0031954) | 3.09821080 |
| 107 | drug transmembrane transport (GO:0006855) | 3.09611140 |
| 108 | ethanol oxidation (GO:0006069) | 3.08997441 |
| 109 | plasma lipoprotein particle assembly (GO:0034377) | 3.07627039 |
| 110 | tyrosine metabolic process (GO:0006570) | 3.06699199 |
| 111 | phospholipid homeostasis (GO:0055091) | 3.06019419 |
| 112 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.05174865 |
| 113 | plasma lipoprotein particle clearance (GO:0034381) | 3.04952331 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 3.04854371 |
| 115 | fatty acid transmembrane transport (GO:1902001) | 3.04785664 |
| 116 | nuclear pore organization (GO:0006999) | 3.04192061 |
| 117 | insulin secretion (GO:0030073) | 3.03232671 |
| 118 | protein prenylation (GO:0018342) | 3.02563815 |
| 119 | prenylation (GO:0097354) | 3.02563815 |
| 120 | polyol catabolic process (GO:0046174) | 2.99346064 |
| 121 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.93281094 |
| 122 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.93170795 |
| 123 | epithelial cell fate commitment (GO:0072148) | 2.92858027 |
| 124 | positive regulation of lipid catabolic process (GO:0050996) | 2.92336466 |
| 125 | fibrinolysis (GO:0042730) | 2.91548779 |
| 126 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.91547681 |
| 127 | nitric oxide mediated signal transduction (GO:0007263) | 2.87514329 |
| 128 | DNA double-strand break processing (GO:0000729) | 2.85404298 |
| 129 | presynaptic membrane organization (GO:0097090) | 2.84344763 |
| 130 | positive regulation of glycolytic process (GO:0045821) | 2.83921407 |
| 131 | synapsis (GO:0007129) | 2.83053376 |
| 132 | protein complex biogenesis (GO:0070271) | 2.82284635 |
| 133 | signal peptide processing (GO:0006465) | 2.79208556 |
| 134 | glycerophospholipid catabolic process (GO:0046475) | 2.75217721 |
| 135 | single strand break repair (GO:0000012) | 2.71110801 |
| 136 | kidney morphogenesis (GO:0060993) | 2.70431579 |
| 137 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.70319480 |
| 138 | dentate gyrus development (GO:0021542) | 2.65638210 |
| 139 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.65086023 |
| 140 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.63215620 |
| 141 | regulation of mitochondrial translation (GO:0070129) | 2.60660124 |
| 142 | positive regulation of meiosis (GO:0045836) | 2.57754048 |
| 143 | dorsal/ventral axis specification (GO:0009950) | 2.57154403 |
| 144 | negative regulation of protein oligomerization (GO:0032460) | 2.55117712 |
| 145 | regulation of meiosis I (GO:0060631) | 2.50007242 |
| 146 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.49843750 |
| 147 | rRNA methylation (GO:0031167) | 2.48773843 |
| 148 | detection of calcium ion (GO:0005513) | 2.47621296 |
| 149 | cullin deneddylation (GO:0010388) | 2.46670637 |
| 150 | chromatin remodeling at centromere (GO:0031055) | 2.46568707 |
| 151 | rRNA modification (GO:0000154) | 2.46435783 |
| 152 | replication fork processing (GO:0031297) | 2.45776054 |
| 153 | atrial cardiac muscle cell action potential (GO:0086014) | 2.45012363 |
| 154 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.44815214 |
| 155 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.44085126 |
| 156 | histone exchange (GO:0043486) | 2.43356214 |
| 157 | prostate gland growth (GO:0060736) | 2.42795721 |
| 158 | establishment of protein localization to Golgi (GO:0072600) | 2.41877480 |
| 159 | negative regulation of membrane potential (GO:0045837) | 2.41618804 |
| 160 | positive regulation of meiotic cell cycle (GO:0051446) | 2.41431510 |
| 161 | positive regulation of peptide hormone secretion (GO:0090277) | 2.39852805 |
| 162 | negative regulation of hormone metabolic process (GO:0032351) | 2.39830517 |
| 163 | protein targeting to Golgi (GO:0000042) | 2.39795321 |
| 164 | negative regulation of neurological system process (GO:0031645) | 2.39704638 |
| 165 | positive regulation of insulin secretion (GO:0032024) | 2.37800337 |
| 166 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.35428258 |
| 167 | CENP-A containing nucleosome assembly (GO:0034080) | 2.35371836 |
| 168 | telomere maintenance via telomerase (GO:0007004) | 2.34934978 |
| 169 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.34634177 |
| 170 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.34634177 |
| 171 | glandular epithelial cell differentiation (GO:0002067) | 2.33461779 |
| 172 | double-strand break repair via homologous recombination (GO:0000724) | 2.31928017 |
| 173 | positive regulation of chromosome segregation (GO:0051984) | 2.31595693 |
| 174 | recombinational repair (GO:0000725) | 2.30904115 |
| 175 | positive regulation of peptide secretion (GO:0002793) | 2.30491460 |
| 176 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.30066274 |
| 177 | somite rostral/caudal axis specification (GO:0032525) | 2.28142443 |
| 178 | proteasome assembly (GO:0043248) | 2.27908873 |
| 179 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.27836810 |
| 180 | branched-chain amino acid catabolic process (GO:0009083) | 2.27522217 |
| 181 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.25900587 |
| 182 | NADH dehydrogenase complex assembly (GO:0010257) | 2.25900587 |
| 183 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.25900587 |
| 184 | sister chromatid cohesion (GO:0007062) | 2.25589027 |
| 185 | keratinocyte development (GO:0003334) | 2.25180420 |
| 186 | negative regulation of gluconeogenesis (GO:0045721) | 2.21182129 |
| 187 | resolution of meiotic recombination intermediates (GO:0000712) | 2.21003477 |
| 188 | negative regulation of dendrite development (GO:2000171) | 2.20475729 |
| 189 | negative regulation of acute inflammatory response (GO:0002674) | 2.19680637 |
| 190 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.19546413 |
| 191 | righting reflex (GO:0060013) | 2.19135940 |
| 192 | protein deneddylation (GO:0000338) | 2.14914347 |
| 193 | regulation of protein glycosylation (GO:0060049) | 2.14860810 |
| 194 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.14768656 |
| 195 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.14768656 |
| 196 | pituitary gland development (GO:0021983) | 2.14471415 |
| 197 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.13185107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.73517601 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.52096284 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.87698785 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.63309202 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.36693701 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.69724284 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.29504171 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.14067718 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.87823903 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.86733222 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.77115038 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.69408069 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.69269114 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.66868030 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.66034214 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.62933888 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.49962628 |
| 18 | FUS_26573619_Chip-Seq_HEK293_Human | 2.47978768 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.47208283 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.43347358 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.40496723 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.33276789 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.32633259 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.27899776 |
| 25 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.24289099 |
| 26 | * EWS_26573619_Chip-Seq_HEK293_Human | 2.23446157 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.23230968 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.19633925 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.14785696 |
| 30 | * P300_19829295_ChIP-Seq_ESCs_Human | 2.12045428 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.07360810 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.06892805 |
| 33 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.02927986 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 2.00107126 |
| 35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98774212 |
| 36 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.95794801 |
| 37 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.93676617 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.91847997 |
| 39 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.90101120 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.89740641 |
| 41 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.88567285 |
| 42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.85718718 |
| 43 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.84830149 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82743145 |
| 45 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.78715310 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.77672677 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71188979 |
| 48 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.70602690 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69335792 |
| 50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.66455873 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66216052 |
| 52 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.64167036 |
| 53 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.61175820 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60711777 |
| 55 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60219305 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56636384 |
| 57 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.53837559 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52788505 |
| 59 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.51056794 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50867748 |
| 61 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.44862753 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.44693157 |
| 63 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43750523 |
| 64 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.43269987 |
| 65 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.42865715 |
| 66 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.42363347 |
| 67 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.42363347 |
| 68 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42090353 |
| 69 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.41042466 |
| 70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39806668 |
| 71 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.39616344 |
| 72 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39498744 |
| 73 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.38904511 |
| 74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.37921783 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37039557 |
| 76 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36985289 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36661031 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.36552778 |
| 79 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33258817 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.32688843 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.32621545 |
| 82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.31880437 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.31306150 |
| 84 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.31297327 |
| 85 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31248506 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29142451 |
| 87 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26532132 |
| 88 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.25731177 |
| 89 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.24153066 |
| 90 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24058467 |
| 91 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23892546 |
| 92 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22486208 |
| 93 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20605429 |
| 94 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.20009234 |
| 95 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.18137919 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18040640 |
| 97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17940234 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17289923 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17231603 |
| 100 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17141909 |
| 101 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.16983107 |
| 102 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.16155550 |
| 103 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.16155550 |
| 104 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13333531 |
| 105 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.13224559 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13101984 |
| 107 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12866945 |
| 108 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12727598 |
| 109 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.12699670 |
| 110 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.11739392 |
| 111 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10482235 |
| 112 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.10342357 |
| 113 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09894618 |
| 114 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08798538 |
| 115 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08316517 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08259942 |
| 117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08117181 |
| 118 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07912575 |
| 119 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.07097099 |
| 120 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.06570990 |
| 121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06414860 |
| 122 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.05598243 |
| 123 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05162368 |
| 124 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.04917251 |
| 125 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.04899029 |
| 126 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04072609 |
| 127 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.03476661 |
| 128 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.03011418 |
| 129 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01650872 |
| 130 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01650872 |
| 131 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99774345 |
| 132 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99537619 |
| 133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98677122 |
| 134 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.98296360 |
| 135 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.98178485 |
| 136 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.95635119 |
| 137 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.95361886 |
| 138 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.95361886 |
| 139 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92928420 |
| 140 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92777680 |
| 141 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92634047 |
| 142 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92523340 |
| 143 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90890008 |
| 144 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.90837507 |
| 145 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90161091 |
| 146 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.87863632 |
| 147 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87857801 |
| 148 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.87353483 |
| 149 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86535156 |
| 150 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86177063 |
| 151 | MYC_22102868_ChIP-Seq_BL_Human | 0.83772531 |
| 152 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82538208 |
| 153 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80421405 |
| 154 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.79718069 |
| 155 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.78629204 |
| 156 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76955975 |
| 157 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.75665005 |
| 158 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.75508975 |
| 159 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.75441316 |
| 160 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73765722 |
| 161 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.73667829 |
| 162 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.72815562 |
| 163 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.72085329 |
| 164 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.70157878 |
| 165 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69397323 |
| 166 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69052318 |
| 167 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68593666 |
| 168 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.67683807 |
| 169 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.67272518 |
| 170 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.66985881 |
| 171 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.66448932 |
| 172 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.65823933 |
| 173 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.64174923 |
| 174 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.63788301 |
| 175 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.62926793 |
| 176 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.62368725 |
| 177 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62001504 |
| 178 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.61393202 |
| 179 | * MYB_26560356_Chip-Seq_TH1_Human | 0.60888699 |
| 180 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.60137670 |
| 181 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.59601559 |
| 182 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.59099861 |
| 183 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.58537100 |
| 184 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58342090 |
| 185 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.57726106 |
| 186 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.57567392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.73854693 |
| 2 | MP0005360_urolithiasis | 6.16435814 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.14600798 |
| 4 | MP0005365_abnormal_bile_salt | 4.74345886 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.86134521 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.70480506 |
| 7 | MP0003787_abnormal_imprinting | 3.65543053 |
| 8 | MP0003252_abnormal_bile_duct | 3.38710775 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 3.10821119 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.73043637 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.64149602 |
| 12 | MP0003283_abnormal_digestive_organ | 2.61195392 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.51654893 |
| 14 | MP0006072_abnormal_retinal_apoptosis | 2.51293348 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.27604527 |
| 16 | MP0005332_abnormal_amino_acid | 2.22798661 |
| 17 | MP0002163_abnormal_gland_morphology | 2.22453655 |
| 18 | MP0005379_endocrine/exocrine_gland_phen | 2.19514232 |
| 19 | MP0003121_genomic_imprinting | 2.10498387 |
| 20 | MP0003123_paternal_imprinting | 2.03701041 |
| 21 | MP0003122_maternal_imprinting | 2.01391195 |
| 22 | MP0009697_abnormal_copulation | 2.00157917 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 1.99963296 |
| 24 | MP0005645_abnormal_hypothalamus_physiol | 1.99853804 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.95590712 |
| 26 | MP0005083_abnormal_biliary_tract | 1.94189934 |
| 27 | MP0002102_abnormal_ear_morphology | 1.89368874 |
| 28 | MP0002909_abnormal_adrenal_gland | 1.87992824 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.86697062 |
| 30 | MP0008058_abnormal_DNA_repair | 1.82993358 |
| 31 | MP0003693_abnormal_embryo_hatching | 1.82542965 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.81716260 |
| 33 | MP0000609_abnormal_liver_physiology | 1.80122278 |
| 34 | MP0010307_abnormal_tumor_latency | 1.80117162 |
| 35 | MP0009840_abnormal_foam_cell | 1.78414952 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.71434735 |
| 37 | MP0001984_abnormal_olfaction | 1.70829044 |
| 38 | MP0005220_abnormal_exocrine_pancreas | 1.69542090 |
| 39 | MP0001944_abnormal_pancreas_morphology | 1.65673390 |
| 40 | MP0003890_abnormal_embryonic-extraembry | 1.64631766 |
| 41 | MP0002938_white_spotting | 1.64279650 |
| 42 | MP0003186_abnormal_redox_activity | 1.62737464 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.62473416 |
| 44 | MP0010094_abnormal_chromosome_stability | 1.60100526 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.58234933 |
| 46 | MP0009046_muscle_twitch | 1.56829237 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 1.55100903 |
| 48 | MP0006292_abnormal_olfactory_placode | 1.50033980 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.48574623 |
| 50 | MP0002693_abnormal_pancreas_physiology | 1.44876148 |
| 51 | MP0005253_abnormal_eye_physiology | 1.44239957 |
| 52 | MP0004957_abnormal_blastocyst_morpholog | 1.42970150 |
| 53 | MP0000598_abnormal_liver_morphology | 1.41084725 |
| 54 | MP0003868_abnormal_feces_composition | 1.39648975 |
| 55 | MP0000631_abnormal_neuroendocrine_gland | 1.39226294 |
| 56 | MP0003718_maternal_effect | 1.36351298 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.34407571 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.33848547 |
| 59 | MP0008057_abnormal_DNA_replication | 1.32815217 |
| 60 | MP0002272_abnormal_nervous_system | 1.30183495 |
| 61 | MP0002160_abnormal_reproductive_system | 1.30128934 |
| 62 | MP0010678_abnormal_skin_adnexa | 1.29334017 |
| 63 | MP0005367_renal/urinary_system_phenotyp | 1.28287453 |
| 64 | MP0000516_abnormal_urinary_system | 1.28287453 |
| 65 | MP0001764_abnormal_homeostasis | 1.27208898 |
| 66 | MP0003195_calcinosis | 1.26707606 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.25998544 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24329825 |
| 69 | MP0009745_abnormal_behavioral_response | 1.24317152 |
| 70 | MP0004215_abnormal_myocardial_fiber | 1.23134646 |
| 71 | MP0000427_abnormal_hair_cycle | 1.21509839 |
| 72 | MP0004270_analgesia | 1.19947066 |
| 73 | MP0002638_abnormal_pupillary_reflex | 1.19272815 |
| 74 | MP0001968_abnormal_touch/_nociception | 1.16444785 |
| 75 | MP0001485_abnormal_pinna_reflex | 1.16223155 |
| 76 | MP0003111_abnormal_nucleus_morphology | 1.15907517 |
| 77 | MP0002090_abnormal_vision | 1.15511263 |
| 78 | MP0001853_heart_inflammation | 1.15221638 |
| 79 | MP0003300_gastrointestinal_ulcer | 1.15098659 |
| 80 | MP0003119_abnormal_digestive_system | 1.13813087 |
| 81 | MP0001835_abnormal_antigen_presentation | 1.10605884 |
| 82 | MP0009643_abnormal_urine_homeostasis | 1.08896903 |
| 83 | MP0005389_reproductive_system_phenotype | 1.07548628 |
| 84 | MP0003567_abnormal_fetal_cardiomyocyte | 1.06943338 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 1.06833022 |
| 86 | MP0009763_increased_sensitivity_to | 1.06484926 |
| 87 | MP0005266_abnormal_metabolism | 1.04278248 |
| 88 | MP0001188_hyperpigmentation | 1.01948980 |
| 89 | MP0002396_abnormal_hematopoietic_system | 1.00613173 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 1.00120568 |
| 91 | MP0008872_abnormal_physiological_respon | 0.99359349 |
| 92 | MP0002736_abnormal_nociception_after | 0.99092698 |
| 93 | MP0003436_decreased_susceptibility_to | 0.98588055 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 0.98449929 |
| 95 | MP0008469_abnormal_protein_level | 0.97483760 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.95896686 |
| 97 | MP0003880_abnormal_central_pattern | 0.95659032 |
| 98 | MP0002254_reproductive_system_inflammat | 0.94020721 |
| 99 | MP0004885_abnormal_endolymph | 0.93001930 |
| 100 | MP0002751_abnormal_autonomic_nervous | 0.92696337 |
| 101 | MP0002234_abnormal_pharynx_morphology | 0.92471627 |
| 102 | MP0002557_abnormal_social/conspecific_i | 0.92114271 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.91727780 |
| 104 | MP0005166_decreased_susceptibility_to | 0.90973624 |
| 105 | MP0005174_abnormal_tail_pigmentation | 0.90865059 |
| 106 | MP0004130_abnormal_muscle_cell | 0.90513422 |
| 107 | MP0003011_delayed_dark_adaptation | 0.89990636 |
| 108 | MP0004133_heterotaxia | 0.88188657 |
| 109 | MP0002064_seizures | 0.87946637 |
| 110 | MP0003077_abnormal_cell_cycle | 0.87792758 |
| 111 | MP0004924_abnormal_behavior | 0.86834233 |
| 112 | MP0005386_behavior/neurological_phenoty | 0.86834233 |
| 113 | MP0001929_abnormal_gametogenesis | 0.86356969 |
| 114 | MP0006036_abnormal_mitochondrial_physio | 0.84645344 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.83781481 |
| 116 | MP0004808_abnormal_hematopoietic_stem | 0.81567547 |
| 117 | MP0009764_decreased_sensitivity_to | 0.81022575 |
| 118 | MP0005647_abnormal_sex_gland | 0.80696037 |
| 119 | MP0002572_abnormal_emotion/affect_behav | 0.80299761 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.79973334 |
| 121 | MP0003786_premature_aging | 0.79972343 |
| 122 | MP0001486_abnormal_startle_reflex | 0.79100193 |
| 123 | MP0006276_abnormal_autonomic_nervous | 0.78834376 |
| 124 | MP0000383_abnormal_hair_follicle | 0.78568652 |
| 125 | MP0001501_abnormal_sleep_pattern | 0.78496792 |
| 126 | MP0000653_abnormal_sex_gland | 0.77688617 |
| 127 | MP0002184_abnormal_innervation | 0.77627624 |
| 128 | MP0003303_peritoneal_inflammation | 0.77525814 |
| 129 | MP0001915_intracranial_hemorrhage | 0.76884153 |
| 130 | MP0003941_abnormal_skin_development | 0.76457768 |
| 131 | MP0002734_abnormal_mechanical_nocicepti | 0.76258372 |
| 132 | MP0002086_abnormal_extraembryonic_tissu | 0.75894978 |
| 133 | MP0002735_abnormal_chemical_nociception | 0.75798102 |
| 134 | MP0004264_abnormal_extraembryonic_tissu | 0.75407617 |
| 135 | MP0001730_embryonic_growth_arrest | 0.74517905 |
| 136 | MP0000647_abnormal_sebaceous_gland | 0.74402727 |
| 137 | MP0009672_abnormal_birth_weight | 0.74389627 |
| 138 | MP0001145_abnormal_male_reproductive | 0.74269525 |
| 139 | MP0001919_abnormal_reproductive_system | 0.73794882 |
| 140 | MP0002210_abnormal_sex_determination | 0.73360628 |
| 141 | MP0002233_abnormal_nose_morphology | 0.73009179 |
| 142 | MP0005376_homeostasis/metabolism_phenot | 0.72745077 |
| 143 | MP0004197_abnormal_fetal_growth/weight/ | 0.72655585 |
| 144 | MP0010386_abnormal_urinary_bladder | 0.72312705 |
| 145 | MP0003075_altered_response_to | 0.71850201 |
| 146 | MP0000490_abnormal_crypts_of | 0.69088547 |
| 147 | MP0010155_abnormal_intestine_physiology | 0.67918763 |
| 148 | MP0005636_abnormal_mineral_homeostasis | 0.67670830 |
| 149 | MP0009765_abnormal_xenobiotic_induced | 0.67658414 |
| 150 | MP0009053_abnormal_anal_canal | 0.67322011 |
| 151 | MP0005451_abnormal_body_composition | 0.65805384 |
| 152 | MP0005025_abnormal_response_to | 0.63981753 |
| 153 | MP0002877_abnormal_melanocyte_morpholog | 0.63730071 |
| 154 | MP0008007_abnormal_cellular_replicative | 0.63531720 |
| 155 | MP0003984_embryonic_growth_retardation | 0.63262234 |
| 156 | MP0001845_abnormal_inflammatory_respons | 0.63260678 |
| 157 | MP0002088_abnormal_embryonic_growth/wei | 0.62923072 |
| 158 | MP0005380_embryogenesis_phenotype | 0.62754986 |
| 159 | MP0001672_abnormal_embryogenesis/_devel | 0.62754986 |
| 160 | MP0008877_abnormal_DNA_methylation | 0.61686150 |
| 161 | MP0002166_altered_tumor_susceptibility | 0.61566227 |
| 162 | MP0002019_abnormal_tumor_incidence | 0.61341624 |
| 163 | MP0009642_abnormal_blood_homeostasis | 0.60802588 |
| 164 | MP0001661_extended_life_span | 0.60595044 |
| 165 | MP0000689_abnormal_spleen_morphology | 0.60436293 |
| 166 | MP0002136_abnormal_kidney_physiology | 0.59961444 |
| 167 | MP0002089_abnormal_postnatal_growth/wei | 0.59714368 |
| 168 | MP0003646_muscle_fatigue | 0.59594359 |
| 169 | MP0008873_increased_physiological_sensi | 0.58722850 |
| 170 | MP0002006_tumorigenesis | 0.58188551 |
| 171 | MP0002282_abnormal_trachea_morphology | 0.57321284 |
| 172 | MP0002928_abnormal_bile_duct | 0.57158276 |
| 173 | MP0002419_abnormal_innate_immunity | 0.57003266 |
| 174 | MP0002269_muscular_atrophy | 0.56796037 |
| 175 | MP0001545_abnormal_hematopoietic_system | 0.55064022 |
| 176 | MP0005397_hematopoietic_system_phenotyp | 0.55064022 |
| 177 | MP0005076_abnormal_cell_differentiation | 0.53974380 |
| 178 | MP0005334_abnormal_fat_pad | 0.53367195 |
| 179 | MP0005084_abnormal_gallbladder_morpholo | 0.53044976 |
| 180 | MP0005377_hearing/vestibular/ear_phenot | 0.51415844 |
| 181 | MP0003878_abnormal_ear_physiology | 0.51415844 |
| 182 | MP0009785_altered_susceptibility_to | 0.51217028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 5.85899398 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.80814186 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.34467564 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.99521511 |
| 5 | Hypoglycemic seizures (HP:0002173) | 4.78958113 |
| 6 | Hypolipoproteinemia (HP:0010981) | 4.67334420 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.60423707 |
| 8 | Xanthomatosis (HP:0000991) | 4.57727998 |
| 9 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.54788578 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.23012745 |
| 11 | Hyperammonemia (HP:0001987) | 4.16943336 |
| 12 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.12485190 |
| 13 | Hypoalphalipoproteinemia (HP:0003233) | 4.10381368 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.08206096 |
| 15 | Joint hemorrhage (HP:0005261) | 4.01579391 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 3.83452021 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.75968702 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.74487288 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.68809473 |
| 20 | Epidermoid cyst (HP:0200040) | 3.62433179 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.58134033 |
| 22 | Complement deficiency (HP:0004431) | 3.56641272 |
| 23 | Neoplasm of the adrenal cortex (HP:0100641) | 3.56164045 |
| 24 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.37619340 |
| 25 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.37619340 |
| 26 | Symptomatic seizures (HP:0011145) | 3.21465664 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.18407781 |
| 28 | Hyperglycemia (HP:0003074) | 3.08585331 |
| 29 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08522470 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.07204998 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.06957353 |
| 32 | Hypochromic microcytic anemia (HP:0004840) | 3.04183052 |
| 33 | Spontaneous abortion (HP:0005268) | 3.03880500 |
| 34 | Ketosis (HP:0001946) | 3.02999466 |
| 35 | Fat malabsorption (HP:0002630) | 3.02884862 |
| 36 | Hepatocellular carcinoma (HP:0001402) | 2.96794155 |
| 37 | Abnormality of the labia minora (HP:0012880) | 2.96417432 |
| 38 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.93431785 |
| 39 | Abnormality of complement system (HP:0005339) | 2.92807078 |
| 40 | Hyperglycinuria (HP:0003108) | 2.91432006 |
| 41 | Myocardial infarction (HP:0001658) | 2.90767204 |
| 42 | Progressive macrocephaly (HP:0004481) | 2.88345722 |
| 43 | Hypothermia (HP:0002045) | 2.79502777 |
| 44 | Intestinal atresia (HP:0011100) | 2.76939742 |
| 45 | Conjugated hyperbilirubinemia (HP:0002908) | 2.76890055 |
| 46 | Spastic diplegia (HP:0001264) | 2.76813406 |
| 47 | Hypercholesterolemia (HP:0003124) | 2.75339192 |
| 48 | Hyperglycinemia (HP:0002154) | 2.75326112 |
| 49 | Hypomagnesemia (HP:0002917) | 2.70885108 |
| 50 | Abnormality of glycine metabolism (HP:0010895) | 2.70737827 |
| 51 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.70737827 |
| 52 | Acanthocytosis (HP:0001927) | 2.70093962 |
| 53 | Vascular calcification (HP:0004934) | 2.69557206 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62500283 |
| 55 | Pancreatic fibrosis (HP:0100732) | 2.62386393 |
| 56 | Abnormality of purine metabolism (HP:0004352) | 2.58680657 |
| 57 | Neoplasm of the adrenal gland (HP:0100631) | 2.58613623 |
| 58 | Pancreatic cysts (HP:0001737) | 2.57798043 |
| 59 | Methylmalonic acidemia (HP:0002912) | 2.57684716 |
| 60 | Thrombophlebitis (HP:0004418) | 2.55252924 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.55181579 |
| 62 | Prominent metopic ridge (HP:0005487) | 2.53184363 |
| 63 | Abnormality of serum amino acid levels (HP:0003112) | 2.47726677 |
| 64 | Conjunctival hamartoma (HP:0100780) | 2.47509613 |
| 65 | Acute necrotizing encephalopathy (HP:0006965) | 2.47122647 |
| 66 | Abnormal pancreas size (HP:0012094) | 2.46340996 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.43508923 |
| 68 | Esophageal varix (HP:0002040) | 2.42877627 |
| 69 | Abnormality of the metopic suture (HP:0005556) | 2.40456709 |
| 70 | Gingival bleeding (HP:0000225) | 2.40205237 |
| 71 | Large for gestational age (HP:0001520) | 2.40188415 |
| 72 | Abnormal tarsal ossification (HP:0008369) | 2.38733203 |
| 73 | Gaze-evoked nystagmus (HP:0000640) | 2.38468247 |
| 74 | Enlarged penis (HP:0000040) | 2.35702504 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.33329057 |
| 76 | Colon cancer (HP:0003003) | 2.29631043 |
| 77 | Hamartoma of the eye (HP:0010568) | 2.29359463 |
| 78 | Aqueductal stenosis (HP:0002410) | 2.28814836 |
| 79 | True hermaphroditism (HP:0010459) | 2.28509807 |
| 80 | Ketoacidosis (HP:0001993) | 2.27640533 |
| 81 | Upper motor neuron abnormality (HP:0002127) | 2.27108627 |
| 82 | Acute encephalopathy (HP:0006846) | 2.23686724 |
| 83 | Nephronophthisis (HP:0000090) | 2.22808385 |
| 84 | Increased purine levels (HP:0004368) | 2.21754024 |
| 85 | Hyperuricemia (HP:0002149) | 2.21754024 |
| 86 | Volvulus (HP:0002580) | 2.20589937 |
| 87 | Hepatic necrosis (HP:0002605) | 2.19745856 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18841303 |
| 89 | Abnormality of vitamin B metabolism (HP:0004340) | 2.18383838 |
| 90 | Abnormality of the renal cortex (HP:0011035) | 2.18014730 |
| 91 | Epileptiform EEG discharges (HP:0011182) | 2.17913787 |
| 92 | Dicarboxylic aciduria (HP:0003215) | 2.17608680 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17608680 |
| 94 | Hyperventilation (HP:0002883) | 2.14486162 |
| 95 | Thrombocytosis (HP:0001894) | 2.13581234 |
| 96 | Hypsarrhythmia (HP:0002521) | 2.12008822 |
| 97 | Cupped ribs (HP:0000887) | 2.11927510 |
| 98 | Metabolic acidosis (HP:0001942) | 2.11051252 |
| 99 | Increased CSF lactate (HP:0002490) | 2.10934541 |
| 100 | Mitochondrial inheritance (HP:0001427) | 2.10474147 |
| 101 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.10472012 |
| 102 | Steatorrhea (HP:0002570) | 2.09754394 |
| 103 | Gout (HP:0001997) | 2.09580438 |
| 104 | Delayed CNS myelination (HP:0002188) | 2.08321603 |
| 105 | Abnormal hair whorl (HP:0010721) | 2.06897768 |
| 106 | Molar tooth sign on MRI (HP:0002419) | 2.05415563 |
| 107 | Abnormality of midbrain morphology (HP:0002418) | 2.05415563 |
| 108 | Broad-based gait (HP:0002136) | 2.04734268 |
| 109 | Furrowed tongue (HP:0000221) | 2.03100400 |
| 110 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.02923159 |
| 111 | Skin nodule (HP:0200036) | 2.02258042 |
| 112 | Protuberant abdomen (HP:0001538) | 1.99849413 |
| 113 | Systemic lupus erythematosus (HP:0002725) | 1.98428447 |
| 114 | Abnormal cartilage morphology (HP:0002763) | 1.96977229 |
| 115 | Methylmalonic aciduria (HP:0012120) | 1.96602246 |
| 116 | Abnormal foot bone ossification (HP:0010675) | 1.95969731 |
| 117 | Thyroid carcinoma (HP:0002890) | 1.95813108 |
| 118 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.95591625 |
| 119 | Congenital primary aphakia (HP:0007707) | 1.95363557 |
| 120 | Nausea (HP:0002018) | 1.94603049 |
| 121 | Gait imbalance (HP:0002141) | 1.94072919 |
| 122 | Abnormality of iron homeostasis (HP:0011031) | 1.92791301 |
| 123 | Calf muscle hypertrophy (HP:0008981) | 1.91323668 |
| 124 | Genital tract atresia (HP:0001827) | 1.89643063 |
| 125 | Hemiparesis (HP:0001269) | 1.88450982 |
| 126 | Abnormality of magnesium homeostasis (HP:0004921) | 1.87824800 |
| 127 | Increased mean platelet volume (HP:0011877) | 1.86689938 |
| 128 | Absent frontal sinuses (HP:0002688) | 1.85752552 |
| 129 | Menorrhagia (HP:0000132) | 1.84488289 |
| 130 | Thyroiditis (HP:0100646) | 1.84190585 |
| 131 | Global brain atrophy (HP:0002283) | 1.82947861 |
| 132 | Hepatocellular necrosis (HP:0001404) | 1.81882284 |
| 133 | Abnormality of the renal medulla (HP:0100957) | 1.81726765 |
| 134 | Optic nerve hypoplasia (HP:0000609) | 1.81392645 |
| 135 | Flat acetabular roof (HP:0003180) | 1.81252377 |
| 136 | Poikilocytosis (HP:0004447) | 1.81137583 |
| 137 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.80701338 |
| 138 | Meningioma (HP:0002858) | 1.80405155 |
| 139 | Ependymoma (HP:0002888) | 1.79946970 |
| 140 | Vaginal atresia (HP:0000148) | 1.79861207 |
| 141 | Exercise-induced muscle cramps (HP:0003710) | 1.78733905 |
| 142 | Abnormal platelet volume (HP:0011876) | 1.78694642 |
| 143 | Arthropathy (HP:0003040) | 1.78552193 |
| 144 | Increased hepatocellular lipid droplets (HP:0006565) | 1.78081529 |
| 145 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.77559003 |
| 146 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76864814 |
| 147 | Cortical dysplasia (HP:0002539) | 1.76331830 |
| 148 | Proximal tubulopathy (HP:0000114) | 1.75425545 |
| 149 | Muscular hypotonia of the trunk (HP:0008936) | 1.74761674 |
| 150 | Neonatal onset (HP:0003623) | 1.74302912 |
| 151 | Back pain (HP:0003418) | 1.74080426 |
| 152 | Gastrointestinal atresia (HP:0002589) | 1.72997420 |
| 153 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72461202 |
| 154 | Myoglobinuria (HP:0002913) | 1.72260774 |
| 155 | Abnormality of lateral ventricle (HP:0030047) | 1.71656461 |
| 156 | Arterial thrombosis (HP:0004420) | 1.71607268 |
| 157 | Hepatoblastoma (HP:0002884) | 1.70461411 |
| 158 | Abnormal drinking behavior (HP:0030082) | 1.70428873 |
| 159 | Polydipsia (HP:0001959) | 1.70428873 |
| 160 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.69390590 |
| 161 | Hypoplasia of the fovea (HP:0007750) | 1.69390590 |
| 162 | Late onset (HP:0003584) | 1.69080146 |
| 163 | Breast carcinoma (HP:0003002) | 1.69070987 |
| 164 | Nephrogenic diabetes insipidus (HP:0009806) | 1.68932858 |
| 165 | Lethargy (HP:0001254) | 1.68477738 |
| 166 | Adenoma sebaceum (HP:0009720) | 1.68266193 |
| 167 | Angiofibromas (HP:0010615) | 1.68266193 |
| 168 | Cerebral edema (HP:0002181) | 1.67505782 |
| 169 | Progressive inability to walk (HP:0002505) | 1.67488616 |
| 170 | Abnormality of urine glucose concentration (HP:0011016) | 1.66743123 |
| 171 | Glycosuria (HP:0003076) | 1.66743123 |
| 172 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.66604169 |
| 173 | Increased circulating renin level (HP:0000848) | 1.66336790 |
| 174 | Glioma (HP:0009733) | 1.65982604 |
| 175 | Abnormality of the astrocytes (HP:0100707) | 1.65873346 |
| 176 | Astrocytoma (HP:0009592) | 1.65873346 |
| 177 | Agnosia (HP:0010524) | 1.65250422 |
| 178 | Abolished electroretinogram (ERG) (HP:0000550) | 1.65219920 |
| 179 | Downturned corners of mouth (HP:0002714) | 1.65154338 |
| 180 | Vitreoretinal degeneration (HP:0000655) | 1.63545256 |
| 181 | Rhabdomyosarcoma (HP:0002859) | 1.62912970 |
| 182 | Abnormality of chromosome stability (HP:0003220) | 1.62894579 |
| 183 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.62582616 |
| 184 | Respiratory failure (HP:0002878) | 1.62486575 |
| 185 | Enlarged kidneys (HP:0000105) | 1.60888805 |
| 186 | Abnormal sex determination (HP:0012244) | 1.60775935 |
| 187 | Impaired platelet aggregation (HP:0003540) | 1.58962990 |
| 188 | Abnormal platelet function (HP:0011869) | 1.58962990 |
| 189 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.58247239 |
| 190 | Renal cortical cysts (HP:0000803) | 1.58212178 |
| 191 | Neoplasm of the liver (HP:0002896) | 1.57045569 |
| 192 | Rhabdomyolysis (HP:0003201) | 1.56133835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDC7 | 3.44228209 |
| 2 | BMPR1B | 3.33178544 |
| 3 | MST4 | 3.20120386 |
| 4 | FGFR2 | 3.03780912 |
| 5 | PKN2 | 3.01867289 |
| 6 | SCYL2 | 2.70978449 |
| 7 | CASK | 2.55597715 |
| 8 | NEK1 | 2.44876080 |
| 9 | FRK | 2.33139114 |
| 10 | NEK9 | 2.28830969 |
| 11 | BCKDK | 2.28528956 |
| 12 | TNIK | 2.27674216 |
| 13 | TRIM28 | 2.27259670 |
| 14 | PASK | 2.08460413 |
| 15 | WEE1 | 2.07630446 |
| 16 | MKNK2 | 1.99707758 |
| 17 | FLT3 | 1.98637826 |
| 18 | WNK3 | 1.98192102 |
| 19 | CDK6 | 1.96640065 |
| 20 | EIF2AK3 | 1.78124352 |
| 21 | ACVR1B | 1.76341554 |
| 22 | LATS1 | 1.75263609 |
| 23 | MAP4K2 | 1.74327332 |
| 24 | BUB1 | 1.73979147 |
| 25 | SIK1 | 1.73978856 |
| 26 | NEK2 | 1.72916234 |
| 27 | PNCK | 1.72013819 |
| 28 | ZAK | 1.66064557 |
| 29 | MST1R | 1.65920395 |
| 30 | PDK4 | 1.60239088 |
| 31 | PDK3 | 1.60239088 |
| 32 | MKNK1 | 1.59683283 |
| 33 | MAP2K3 | 1.58037070 |
| 34 | NLK | 1.51891188 |
| 35 | ERBB4 | 1.51074017 |
| 36 | MAP3K4 | 1.49267092 |
| 37 | EIF2AK1 | 1.47980800 |
| 38 | EEF2K | 1.47673443 |
| 39 | NME2 | 1.45098396 |
| 40 | CDK12 | 1.44417786 |
| 41 | MAPK11 | 1.44390686 |
| 42 | TSSK6 | 1.43104717 |
| 43 | STK39 | 1.36223549 |
| 44 | GRK1 | 1.35555521 |
| 45 | TRIB3 | 1.34575160 |
| 46 | TAF1 | 1.34265588 |
| 47 | CDK4 | 1.32661982 |
| 48 | RPS6KA4 | 1.30899185 |
| 49 | PIK3CA | 1.29741215 |
| 50 | PHKG2 | 1.29588002 |
| 51 | PHKG1 | 1.29588002 |
| 52 | TTK | 1.28659871 |
| 53 | ERBB3 | 1.28602626 |
| 54 | PIM1 | 1.27949361 |
| 55 | MAP3K8 | 1.24041196 |
| 56 | STK3 | 1.21891048 |
| 57 | ATR | 1.19911798 |
| 58 | PLK2 | 1.14627480 |
| 59 | PLK3 | 1.13775158 |
| 60 | AURKB | 1.11135083 |
| 61 | MAP3K3 | 1.10701295 |
| 62 | NTRK3 | 1.09849282 |
| 63 | NUAK1 | 1.09832200 |
| 64 | OXSR1 | 1.08107413 |
| 65 | CSNK1G1 | 1.07531778 |
| 66 | PLK1 | 1.05706405 |
| 67 | ADRBK2 | 1.04490799 |
| 68 | STK10 | 1.03332382 |
| 69 | MAP3K14 | 1.01494469 |
| 70 | SGK3 | 1.00769860 |
| 71 | MAP3K5 | 1.00713581 |
| 72 | TAOK3 | 1.00400852 |
| 73 | RIPK1 | 0.98258016 |
| 74 | TEC | 0.98195508 |
| 75 | INSRR | 0.97750310 |
| 76 | CSF1R | 0.97211769 |
| 77 | STK16 | 0.96231310 |
| 78 | MAP3K9 | 0.96094074 |
| 79 | TYK2 | 0.95581828 |
| 80 | DAPK2 | 0.92822419 |
| 81 | WNK4 | 0.91022922 |
| 82 | MAP3K2 | 0.90774324 |
| 83 | TLK1 | 0.89189918 |
| 84 | ALK | 0.88790833 |
| 85 | TTN | 0.88685033 |
| 86 | PRKCG | 0.88217267 |
| 87 | PTK6 | 0.86633603 |
| 88 | MAP3K10 | 0.86317936 |
| 89 | STK38L | 0.84865812 |
| 90 | RPS6KB1 | 0.84779696 |
| 91 | STK4 | 0.80560692 |
| 92 | PDK2 | 0.80331274 |
| 93 | SGK2 | 0.80301406 |
| 94 | RPS6KB2 | 0.79582440 |
| 95 | CAMK1D | 0.78268247 |
| 96 | CDK7 | 0.77376461 |
| 97 | VRK1 | 0.75938407 |
| 98 | PRKCE | 0.75593273 |
| 99 | VRK2 | 0.74975535 |
| 100 | ABL2 | 0.74860184 |
| 101 | ATM | 0.74322190 |
| 102 | MAP2K4 | 0.73442231 |
| 103 | CHEK1 | 0.72630156 |
| 104 | MATK | 0.72167207 |
| 105 | PDK1 | 0.71905943 |
| 106 | CHEK2 | 0.71560766 |
| 107 | CSK | 0.70087959 |
| 108 | BMX | 0.69641715 |
| 109 | STK24 | 0.68860499 |
| 110 | BRD4 | 0.67531871 |
| 111 | CCNB1 | 0.67391919 |
| 112 | CSNK1G2 | 0.66325479 |
| 113 | ERN1 | 0.66244696 |
| 114 | AKT2 | 0.66116586 |
| 115 | MAPK13 | 0.65881958 |
| 116 | PAK3 | 0.65437430 |
| 117 | PBK | 0.65302084 |
| 118 | GRK6 | 0.63874784 |
| 119 | OBSCN | 0.62192561 |
| 120 | TAOK2 | 0.61393139 |
| 121 | MAP3K7 | 0.60936241 |
| 122 | MAP4K1 | 0.60088179 |
| 123 | CSNK1G3 | 0.58412465 |
| 124 | TGFBR1 | 0.58120961 |
| 125 | CDK2 | 0.56741130 |
| 126 | JAK2 | 0.55775161 |
| 127 | CAMK1G | 0.55698757 |
| 128 | AKT3 | 0.55006899 |
| 129 | SRPK1 | 0.54916861 |
| 130 | DYRK1B | 0.51899302 |
| 131 | FGFR3 | 0.51392534 |
| 132 | CSNK2A2 | 0.51026703 |
| 133 | MAP3K6 | 0.50833724 |
| 134 | FER | 0.49723703 |
| 135 | BCR | 0.49538787 |
| 136 | CDK3 | 0.49432628 |
| 137 | EIF2AK2 | 0.49429893 |
| 138 | MAP2K7 | 0.48079834 |
| 139 | TBK1 | 0.47921257 |
| 140 | PLK4 | 0.47521564 |
| 141 | DYRK2 | 0.47360427 |
| 142 | LRRK2 | 0.47317453 |
| 143 | KIT | 0.46201273 |
| 144 | BRSK2 | 0.46080126 |
| 145 | PRKCI | 0.45573501 |
| 146 | PINK1 | 0.45058384 |
| 147 | PRKAA2 | 0.44662492 |
| 148 | IRAK1 | 0.43184312 |
| 149 | LYN | 0.41663025 |
| 150 | FGFR1 | 0.41483240 |
| 151 | CAMK2D | 0.41231394 |
| 152 | CSNK2A1 | 0.40931299 |
| 153 | MARK3 | 0.40646828 |
| 154 | MTOR | 0.40062324 |
| 155 | STK11 | 0.39626897 |
| 156 | TRPM7 | 0.39230943 |
| 157 | CSNK1A1L | 0.38589277 |
| 158 | CSNK1E | 0.37209946 |
| 159 | YES1 | 0.34697827 |
| 160 | DAPK1 | 0.32620670 |
| 161 | PRKDC | 0.32618322 |
| 162 | SGK223 | 0.31028000 |
| 163 | SGK494 | 0.31028000 |
| 164 | CSNK1D | 0.30757390 |
| 165 | CAMK2A | 0.29474155 |
| 166 | PRKACB | 0.27288943 |
| 167 | HIPK2 | 0.26971562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.96664414 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.58246877 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.66160169 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.52483143 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.24659020 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.18527211 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97785767 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57246850 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.56567580 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35606672 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.34983051 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.33287170 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16038445 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.15547405 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.11145745 |
| 16 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.97057373 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.95630789 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.89373043 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.84431454 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.84056662 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83538560 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.80931737 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79129792 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.78492256 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.77661735 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.76076860 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.68526778 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68379951 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61116253 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59859897 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58403346 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57263975 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.57112877 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54998685 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.53194522 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52460155 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49660349 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49441740 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48818480 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47587091 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46750818 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46134541 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.44165700 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44156508 |
| 45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.43455285 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41562277 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.41169688 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.39855157 |
| 49 | DNA replication_Homo sapiens_hsa03030 | 1.38657290 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 1.37289430 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.34826412 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.29967821 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24808282 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.23265621 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.21051406 |
| 56 | Parkinsons disease_Homo sapiens_hsa05012 | 1.14285681 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 1.09157877 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08769536 |
| 59 | Circadian rhythm_Homo sapiens_hsa04710 | 1.08025280 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.07816279 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06269333 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 1.05018346 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.02558306 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 1.00606489 |
| 65 | Purine metabolism_Homo sapiens_hsa00230 | 0.99116692 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98874253 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94415638 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91583804 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 0.91315709 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.91079948 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90349344 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89198695 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.88604354 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.88546741 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86249301 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85500366 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83752944 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83389471 |
| 79 | Huntingtons disease_Homo sapiens_hsa05016 | 0.82500294 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82440726 |
| 81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81612905 |
| 82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.81361586 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80964407 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80216853 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.78557447 |
| 86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.78450548 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.72953346 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.72659941 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71494472 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71212716 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67795458 |
| 92 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.67694131 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.67675632 |
| 94 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.67180958 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.66958107 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.62812207 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61803388 |
| 98 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.60449505 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59648279 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58923395 |
| 101 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58637972 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58173928 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56991330 |
| 104 | Long-term depression_Homo sapiens_hsa04730 | 0.55786272 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54441989 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54107922 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52192670 |
| 108 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.51241604 |
| 109 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50284240 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49874566 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48422565 |
| 112 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.48193011 |
| 113 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.46233573 |
| 114 | RNA transport_Homo sapiens_hsa03013 | 0.45732619 |
| 115 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44136884 |
| 116 | Salivary secretion_Homo sapiens_hsa04970 | 0.40230535 |
| 117 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.39540536 |
| 118 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.37705999 |
| 119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37418047 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36721169 |
| 121 | Base excision repair_Homo sapiens_hsa03410 | 0.35745232 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35682750 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35174172 |
| 124 | Cell cycle_Homo sapiens_hsa04110 | 0.32974176 |
| 125 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.32533393 |
| 126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31606567 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.25577560 |
| 128 | Legionellosis_Homo sapiens_hsa05134 | 0.25352991 |
| 129 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24655993 |
| 130 | Homologous recombination_Homo sapiens_hsa03440 | 0.22792260 |
| 131 | RNA degradation_Homo sapiens_hsa03018 | 0.22755676 |
| 132 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.19523617 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17459050 |
| 134 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.17185715 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13472689 |
| 136 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.13066088 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12310068 |
| 138 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10662202 |
| 139 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.10077012 |
| 140 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.09968707 |
| 141 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.07770525 |
| 142 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.04002924 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.01627354 |
| 144 | Thyroid cancer_Homo sapiens_hsa05216 | 0.01085336 |
| 145 | p53 signaling pathway_Homo sapiens_hsa04115 | -0.0143773 |
| 146 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.0101704 |
| 147 | Spliceosome_Homo sapiens_hsa03040 | -0.0044423 |
| 148 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0044312 |
| 149 | Viral myocarditis_Homo sapiens_hsa05416 | -0.0037402 |

